Invention Grant
- Patent Title: Process for making nucleoside phosphoramidate compounds
-
Application No.: US15519846Application Date: 2015-10-20
-
Publication No.: US10251903B2Publication Date: 2019-04-09
- Inventor: Bryon L. Simmons , Kevin R. Campos , Artis Klapars , Alistair J. Stewart , Benjamin A. Mayes , Peter E. Maligres , Alan Hyde , Steven Mark Silverman , Yong-Li Zhong , Adel M. Moussa , Kenneth Baker , Kara Van Valkenburg
- Applicant: MERCK SHARP & DOHME CORP. , IDENIX Pharmaceuticals LLC , Bryon L. Simmons , Kevin R. Campos , Artis Klapars , Alistair J. Stewart , Benjamin A. Mayes , Peter E. Maligres , Alan Hyde , Steven Mark Silverman , Yong-Li Zhong , Adel M. Moussa , Kenneth Baker , Kara Van Valkenburg
- Applicant Address: US NJ Rahway US MA Cambridge
- Assignee: Merck Sharp & Dohme Corp.,Idenix Pharmaceuticals LLC
- Current Assignee: Merck Sharp & Dohme Corp.,Idenix Pharmaceuticals LLC
- Current Assignee Address: US NJ Rahway US MA Cambridge
- Agent Jeffrey P. Bergman; Catherine D. Fitch
- International Application: PCT/US2015/056333 WO 20151020
- International Announcement: WO2016/064797 WO 20160428
- Main IPC: C07H19/10
- IPC: C07H19/10 ; A61K31/7052 ; C07H1/00 ; C08K3/08
Abstract:
The present invention is directed to a process for making Nucleoside Phosphoramidate Compounds of formula (I): which are useful for the treatment and prophylaxis of HCV infection. The present invention is also directed to compounds that are useful as synthetic intermediates for making the compounds of formula (I).
Public/Granted literature
- US20170246198A1 Process for Making Nucleoside Phosphoramidate Compounds Public/Granted day:2017-08-31
Information query
IPC分类:
